Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Q4 2024 Management View Anders Danielsson, President and CEO, highlighted strong Q4 results, emphasizing a record-high order backlog of SEK 285 billion, driven by robust order bookings with a ...

OceanFirst Financial is a New Jersey-based bank. Read more about a comparison between OCFC's common stock and preferred ...

During 2024, MCB attracted home remittance inflows of USD 4,592 million (+41%), improving market share to 13.2%, to further ...

Pandox AB (PNDXF) reports robust revenue growth and strategic investments, despite challenges in certain markets.

Shares of less-than-truckload carrier XPO were up 9% in midday trading on Thursday following a fifth consecutive quarter of ...

Q4 2024 Management View CEO Rohit Gupta highlighted 2024 as a record year for Enact Holdings, with adjusted operating income reaching $718 million, a 9% year-over-year increase. This was attributed to ...

SEBI introduces new disclosure regulation for mutual funds, emphasizing Information Ratio to measure scheme performance ...

Corpay, Inc. (NYSE: CPAY), a corporate payments company, today reported financial results for its fourth quarter and year ended December 31, 2024.

In a post written last week, colleague Peter Baracchini offered an in-depth look at Max Domi’s underwhelming performance with ...

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), a leader in data security, today announced financial results for the fourth quarter and full-year ended December 31, ...